Faye V Andrews1, Ellen Smit2, Barrett M Welch3, Sharia M Ahmed4, Molly L Kile2. 1. Oregon State University, College of Public Health and Human Sciences, Corvallis, OR, USA. Electronic address: andrewsf@oregonstate.edu. 2. Oregon State University, College of Public Health and Human Sciences, Corvallis, OR, USA. 3. National Institute of Environmental Health Sciences, Research Triangle Park, NC, USA. 4. University of Utah School of Medicine, Salt Lake City, UT, USA.
Abstract
BACKGROUND: Polycyclic aromatic hydrocarbons (PAHs) are environmental contaminants that are hepatotoxic and immunotoxic. PAH exposure may modulate hepatitis B immunology. OBJECTIVE: We used data from 6 cycles of the National Health and Nutrition Examination Survey (2003-2014) to evaluate the associations between urinary PAH metabolites and hepatitis B serology. METHODS: This analysis included individuals who self-reported receiving ≥3 doses of hepatitis B vaccine and urinary PAH metabolites (i.e. 1-napthol, 2-napthol, 3-fluorene, 2-fluorene, 1-phenanthrene, 1-pyrene, and total PAH [sum of all metabolites]). Separate logistic regression models assessed the association between hepatitis B vaccination status (i.e. individuals who were immune due to vaccination or susceptible) and tertiles of urinary PAH. Models were adjusted for age, gender, race/ethnicity, survey cycle, family income to poverty ratio, BMI, country of birth, serum cotinine, and urinary creatinine. RESULTS: Among participants who reported receiving ≥3 doses of vaccine and had no antibodies indicating a history of hepatitis B infection and/or current hepatitis B infection, dose-response relationships were observed where individuals with the lowest odds of serology indicating a response to the hepatitis B vaccine (i.e., anti-HBs+, anti-HBc-, and HBsAg-) were in the highest tertile of 2-Napthol (adjusted Odds Ratio [aOR]: 0.70, 95% confidence interval [CI]: 0.54, 0.91), 3-Napthol (aOR: 0.68, 95% CI: 0.53, 0.87), 2-Fluorene (aOR: 0.61, 95% CI: 0.54, 0.86), 1-Phenanthrene (aOR: 0.79, 95% CI: 0.65, 0.97), 1-Pyrene (aOR): 0.68, 95% CI: 0.55, 0.83), and total PAH (aOR: 0.73, 95% CI: 0.56, 0.95) had the compared to the lowest tertile. CONCLUSION: This cross-sectional study supports a hypothesis that PAH exposures experienced by the general US population may modulate hepatitis B vaccine induced immunity. Given the ubiquity of PAH exposures in the US, additional research is warranted to explore the effects of chronic PAH exposures on hepatitis B related humoral immunity.
BACKGROUND: Polycyclic aromatic hydrocarbons (PAHs) are environmental contaminants that are hepatotoxic and immunotoxic. PAH exposure may modulate hepatitis B immunology. OBJECTIVE: We used data from 6 cycles of the National Health and Nutrition Examination Survey (2003-2014) to evaluate the associations between urinary PAH metabolites and hepatitis B serology. METHODS: This analysis included individuals who self-reported receiving ≥3 doses of hepatitis B vaccine and urinary PAH metabolites (i.e. 1-napthol, 2-napthol, 3-fluorene, 2-fluorene, 1-phenanthrene, 1-pyrene, and total PAH [sum of all metabolites]). Separate logistic regression models assessed the association between hepatitis B vaccination status (i.e. individuals who were immune due to vaccination or susceptible) and tertiles of urinary PAH. Models were adjusted for age, gender, race/ethnicity, survey cycle, family income to poverty ratio, BMI, country of birth, serum cotinine, and urinary creatinine. RESULTS: Among participants who reported receiving ≥3 doses of vaccine and had no antibodies indicating a history of hepatitis B infection and/or current hepatitis B infection, dose-response relationships were observed where individuals with the lowest odds of serology indicating a response to the hepatitis B vaccine (i.e., anti-HBs+, anti-HBc-, and HBsAg-) were in the highest tertile of 2-Napthol (adjusted Odds Ratio [aOR]: 0.70, 95% confidence interval [CI]: 0.54, 0.91), 3-Napthol (aOR: 0.68, 95% CI: 0.53, 0.87), 2-Fluorene (aOR: 0.61, 95% CI: 0.54, 0.86), 1-Phenanthrene (aOR: 0.79, 95% CI: 0.65, 0.97), 1-Pyrene (aOR): 0.68, 95% CI: 0.55, 0.83), and total PAH (aOR: 0.73, 95% CI: 0.56, 0.95) had the compared to the lowest tertile. CONCLUSION: This cross-sectional study supports a hypothesis that PAH exposures experienced by the general US population may modulate hepatitis B vaccine induced immunity. Given the ubiquity of PAH exposures in the US, additional research is warranted to explore the effects of chronic PAH exposures on hepatitis B related humoral immunity.
Authors: Darrell R Boverhof; Greg Ladics; Bob Luebke; Jane Botham; Emanuela Corsini; Ellen Evans; Dori Germolec; Michael Holsapple; Scott E Loveless; Haitian Lu; Jan Willem van der Laan; Kimber L White; Yung Yang Journal: Regul Toxicol Pharmacol Date: 2013-11-23 Impact factor: 3.271
Authors: D E Craven; Z L Awdeh; L M Kunches; E J Yunis; J L Dienstag; B G Werner; B F Polk; D R Syndman; R Platt; C S Crumpacker Journal: Ann Intern Med Date: 1986-09 Impact factor: 25.391
Authors: Barrett M Welch; Adam Branscum; Sharia M Ahmed; Perry Hystad; Ellen Smit; Sakila Afroz; Meghan Megowan; Mostofa Golam; Md Omar Sharif Ibne Hasan; Mohammad L Rahman; Quazi Quamruzzaman; David C Christiani; Molly L Kile Journal: Environ Int Date: 2019-04-30 Impact factor: 9.621
Authors: W Szmuness; C E Stevens; E J Harley; E A Zang; H J Alter; P E Taylor; A DeVera; G T Chen; A Kellner Journal: N Engl J Med Date: 1982-12-09 Impact factor: 91.245
Authors: Irva Hertz-Picciotto; Caroline E W Herr; Poh-Sin Yap; Miroslav Dostál; Robert H Shumway; Paul Ashwood; Michael Lipsett; Jesse P Joad; Kent E Pinkerton; Radim J Srám Journal: Environ Health Perspect Date: 2005-10 Impact factor: 9.031